Trials / Completed
CompletedNCT00929331
Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years
Immunogenicity and Safety Study of GSK Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study is designed to test the safety and immunogenicity of Fluviral® (2009 - 2010 Season) in adults aged 18 to 60 years and over 60 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Fluviral® | Intramuscular injection, one dose |
Timeline
- Start date
- 2009-07-11
- Primary completion
- 2009-08-01
- Completion
- 2009-08-01
- First posted
- 2009-06-29
- Last updated
- 2020-11-09
- Results posted
- 2010-08-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00929331. Inclusion in this directory is not an endorsement.